US Stock MarketDetailed Quotes

Milestone Pharmaceuticals (MIST)

Watchlist
  • 1.980
  • -0.010-0.50%
Close Jan 23 16:00 ET
  • 1.990
  • +0.010+0.51%
Post 20:01 ET
168.64MMarket Cap-2.51P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Milestone Pharmaceuticals (MIST) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-38.90%-9.75M
-107.60%-12.57M
-56.17%-13.95M
37.86%-28.85M
30.14%-6.84M
42.29%-7.02M
42.70%-6.05M
35.75%-8.93M
11.52%-46.42M
23.84%-9.8M
Net income from continuing operations
-26.31%-11.92M
-38.48%-12.97M
-100.51%-20.76M
30.44%-41.52M
9.17%-12.36M
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
Operating gains losses
----
----
----
--8K
--0
--0
----
----
----
----
Depreciation and amortization
0.00%25K
7.69%28K
-3.57%27K
14.13%105K
0.00%26K
4.17%25K
8.33%26K
55.56%28K
3.37%92K
73.33%26K
Other non cash items
7.20%968K
7.22%951K
7.22%935K
40.17%3.58M
7.12%918K
7.24%903K
--887K
--872K
--2.55M
--857K
Change In working capital
-133.17%-69K
-267.29%-1.89M
609.12%4.58M
194.13%3.66M
182.86%3.22M
126.36%208K
-46.51%1.13M
26.01%-899K
138.11%1.24M
160.31%1.14M
-Change in receivables
43.48%495K
158.74%158K
-86.68%230K
155.34%1.46M
80.52%-343K
166.99%345K
-150.47%-269K
292.96%1.73M
-261.37%-2.64M
-202.06%-1.76M
-Change in prepaid assets
-125.80%-1.83M
147.77%1.61M
-163.24%-516K
-52.67%1.34M
-81.95%683K
48.11%-810K
1,280.85%649K
46.24%816K
265.71%2.83M
499.47%3.78M
-Change in payables and accrued expense
88.31%1.27M
-585.77%-3.65M
241.78%4.87M
-15.54%875K
418.47%2.88M
-47.88%676K
-50.59%752K
-290.44%-3.43M
214.22%1.04M
-131.20%-904K
-Change in other working capital
-166.67%-8K
--0
70.00%-3K
-194.44%-17K
--0
70.00%-3K
-157.14%-4K
-1,100.00%-10K
-77.78%18K
-41.18%20K
Cash from discontinued investing activities
Operating cash flow
-38.90%-9.75M
-107.60%-12.57M
-56.17%-13.95M
37.86%-28.85M
30.14%-6.84M
42.29%-7.02M
42.70%-6.05M
35.75%-8.93M
11.52%-46.42M
23.84%-9.8M
Investing cash flow
Cash flow from continuing investing activities
-639.79%-34.98M
4.87%9.94M
224.32%33.58M
74.16%8.28M
41.37%19.33M
159.69%6.48M
133.83%9.48M
-190.14%-27.01M
108.33%4.76M
180.38%13.68M
Net PPE purchase and sale
50.00%-2K
-57.14%-11K
---6K
70.54%-33K
29.03%-22K
77.78%-4K
77.42%-7K
--0
58.82%-112K
71.82%-31K
Net investment purchase and sale
-639.43%-34.98M
4.91%9.96M
224.34%33.59M
70.83%8.32M
41.21%19.36M
159.83%6.49M
133.89%9.49M
-190.05%-27.01M
108.56%4.87M
181.08%13.71M
Cash from discontinued investing activities
Investing cash flow
-639.79%-34.98M
4.87%9.94M
224.32%33.58M
74.16%8.28M
41.37%19.33M
159.69%6.48M
133.83%9.48M
-190.14%-27.01M
108.33%4.76M
180.38%13.68M
Financing cash flow
Cash flow from continuing financing activities
66,005.41%48.92M
112.08%36K
-99.57%140K
-32.79%32.12M
2,300.00%24K
-75.74%74K
89.23%-298K
-35.69%32.32M
1,447.67%47.79M
-99.56%1K
Net issuance payments of debt
----
----
----
--0
--0
--0
--0
--0
--50M
--0
Net common stock issuance
--46.06M
--0
--0
--27.26M
--0
--0
---280K
--27.54M
--0
--0
Proceeds from stock option exercised by employees
3,758.11%2.86M
300.00%36K
-97.07%140K
746.86%4.86M
2,300.00%24K
-75.74%74K
-220.00%-18K
1,789.72%4.78M
25.33%574K
-99.59%1K
Net other financing activities
----
----
----
----
----
----
----
----
---2.78M
--0
Cash from discontinued financing activities
Financing cash flow
66,005.41%48.92M
112.08%36K
-99.57%140K
-32.79%32.12M
2,300.00%24K
-75.74%74K
89.23%-298K
-35.69%32.32M
1,447.67%47.79M
-99.56%1K
Net cash flow
Beginning cash position
220.46%42.5M
345.02%45.09M
83.97%25.31M
80.20%13.76M
29.56%12.8M
-59.31%13.26M
-86.30%10.13M
80.20%13.76M
-93.31%7.64M
-73.50%9.88M
Current changes in cash
1,004.10%4.19M
-182.59%-2.59M
644.81%19.77M
88.67%11.55M
222.47%12.52M
97.96%-463K
107.57%3.13M
-105.47%-3.63M
105.75%6.12M
113.09%3.88M
End cash Position
264.76%46.69M
220.46%42.5M
345.02%45.09M
83.97%25.31M
83.97%25.31M
29.56%12.8M
-59.31%13.26M
-86.30%10.13M
80.20%13.76M
80.20%13.76M
Free cash flow
-38.85%-9.75M
-107.54%-12.58M
-56.23%-13.96M
37.94%-28.88M
30.14%-6.87M
42.34%-7.02M
42.80%-6.06M
35.89%-8.93M
11.77%-46.54M
24.24%-9.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -38.90%-9.75M-107.60%-12.57M-56.17%-13.95M37.86%-28.85M30.14%-6.84M42.29%-7.02M42.70%-6.05M35.75%-8.93M11.52%-46.42M23.84%-9.8M
Net income from continuing operations -26.31%-11.92M-38.48%-12.97M-100.51%-20.76M30.44%-41.52M9.17%-12.36M37.41%-9.44M41.64%-9.36M30.74%-10.35M-2.22%-59.69M-3.29%-13.61M
Operating gains losses --------------8K--0--0----------------
Depreciation and amortization 0.00%25K7.69%28K-3.57%27K14.13%105K0.00%26K4.17%25K8.33%26K55.56%28K3.37%92K73.33%26K
Other non cash items 7.20%968K7.22%951K7.22%935K40.17%3.58M7.12%918K7.24%903K--887K--872K--2.55M--857K
Change In working capital -133.17%-69K-267.29%-1.89M609.12%4.58M194.13%3.66M182.86%3.22M126.36%208K-46.51%1.13M26.01%-899K138.11%1.24M160.31%1.14M
-Change in receivables 43.48%495K158.74%158K-86.68%230K155.34%1.46M80.52%-343K166.99%345K-150.47%-269K292.96%1.73M-261.37%-2.64M-202.06%-1.76M
-Change in prepaid assets -125.80%-1.83M147.77%1.61M-163.24%-516K-52.67%1.34M-81.95%683K48.11%-810K1,280.85%649K46.24%816K265.71%2.83M499.47%3.78M
-Change in payables and accrued expense 88.31%1.27M-585.77%-3.65M241.78%4.87M-15.54%875K418.47%2.88M-47.88%676K-50.59%752K-290.44%-3.43M214.22%1.04M-131.20%-904K
-Change in other working capital -166.67%-8K--070.00%-3K-194.44%-17K--070.00%-3K-157.14%-4K-1,100.00%-10K-77.78%18K-41.18%20K
Cash from discontinued investing activities
Operating cash flow -38.90%-9.75M-107.60%-12.57M-56.17%-13.95M37.86%-28.85M30.14%-6.84M42.29%-7.02M42.70%-6.05M35.75%-8.93M11.52%-46.42M23.84%-9.8M
Investing cash flow
Cash flow from continuing investing activities -639.79%-34.98M4.87%9.94M224.32%33.58M74.16%8.28M41.37%19.33M159.69%6.48M133.83%9.48M-190.14%-27.01M108.33%4.76M180.38%13.68M
Net PPE purchase and sale 50.00%-2K-57.14%-11K---6K70.54%-33K29.03%-22K77.78%-4K77.42%-7K--058.82%-112K71.82%-31K
Net investment purchase and sale -639.43%-34.98M4.91%9.96M224.34%33.59M70.83%8.32M41.21%19.36M159.83%6.49M133.89%9.49M-190.05%-27.01M108.56%4.87M181.08%13.71M
Cash from discontinued investing activities
Investing cash flow -639.79%-34.98M4.87%9.94M224.32%33.58M74.16%8.28M41.37%19.33M159.69%6.48M133.83%9.48M-190.14%-27.01M108.33%4.76M180.38%13.68M
Financing cash flow
Cash flow from continuing financing activities 66,005.41%48.92M112.08%36K-99.57%140K-32.79%32.12M2,300.00%24K-75.74%74K89.23%-298K-35.69%32.32M1,447.67%47.79M-99.56%1K
Net issuance payments of debt --------------0--0--0--0--0--50M--0
Net common stock issuance --46.06M--0--0--27.26M--0--0---280K--27.54M--0--0
Proceeds from stock option exercised by employees 3,758.11%2.86M300.00%36K-97.07%140K746.86%4.86M2,300.00%24K-75.74%74K-220.00%-18K1,789.72%4.78M25.33%574K-99.59%1K
Net other financing activities -----------------------------------2.78M--0
Cash from discontinued financing activities
Financing cash flow 66,005.41%48.92M112.08%36K-99.57%140K-32.79%32.12M2,300.00%24K-75.74%74K89.23%-298K-35.69%32.32M1,447.67%47.79M-99.56%1K
Net cash flow
Beginning cash position 220.46%42.5M345.02%45.09M83.97%25.31M80.20%13.76M29.56%12.8M-59.31%13.26M-86.30%10.13M80.20%13.76M-93.31%7.64M-73.50%9.88M
Current changes in cash 1,004.10%4.19M-182.59%-2.59M644.81%19.77M88.67%11.55M222.47%12.52M97.96%-463K107.57%3.13M-105.47%-3.63M105.75%6.12M113.09%3.88M
End cash Position 264.76%46.69M220.46%42.5M345.02%45.09M83.97%25.31M83.97%25.31M29.56%12.8M-59.31%13.26M-86.30%10.13M80.20%13.76M80.20%13.76M
Free cash flow -38.85%-9.75M-107.54%-12.58M-56.23%-13.96M37.94%-28.88M30.14%-6.87M42.34%-7.02M42.80%-6.06M35.89%-8.93M11.77%-46.54M24.24%-9.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.28%
Sample Name
Sample Code
 +3.09%
Sample Name
Sample Code
 +2.74%
4
Amazon
AMZN
+2.06%
5
Clean Energy Fuels
CLNE
+1.75%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +20.18%
Sample Name
Sample Code
 +8.06%
Sample Name
Sample Code
 +4.49%
4
KE Holdings
BEKE
+3.82%
5
Pony AI
PONY
+3.59%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -